Our Services
Medical Information
Helpful Resources
Published on: 9/12/2026
End-stage (stage 4) cirrhosis often signals that life expectancy is short through deepening jaundice, fluid buildup in the abdomen and legs that no longer responds to diuretics, hepatic encephalopathy causing confusion, disorientation or excessive sleepiness, internal bleeding from varices seen as vomiting blood or black stools, declining kidney function, repeated infections, severe muscle and weight loss, and long periods of sleep with little appetite or interest in food. Several other factors, including how quickly symptoms are changing and which complications appear together, affect what these signs mean for any individual, so see below to understand more before drawing conclusions. Because many of these warning signs overlap with treatable complications that can improve with prompt care, timing matters and guessing can be costly.
If you or someone you love is experiencing any of these changes, take a few minutes for a free, instant, online symptom check to clarify what the symptoms may indicate and what level of care is appropriate right now. It is private, takes just a moment, and can help you walk into a conversation with a doctor or hospice team already knowing the right questions to ask.
Last reviewed for medical accuracy: 09/12/2026
Cirrhosis is the scarring of the liver caused by long-term damage. It progresses from early, compensated stages (1–2), through an intermediate stage (3), and finally to decompensated cirrhosis (stage 4). As scarring worsens, the liver loses its ability to function, leading to serious complications.
Below, we’ll cover:
This information is based on credible hepatology guidelines and peer-reviewed studies. If you notice any worrying symptoms or changes, speak to a doctor right away.
Stage 3 cirrhosis—sometimes called “pre-decompensated”—is marked by serious scarring but no major complications yet. Common features include:
Life expectancy at stage 3 varies greatly depending on overall health, cause of liver injury, and how well complications (like varices) are managed:
Stage 4 cirrhosis, also called decompensated cirrhosis, means the liver can no longer keep up with body demands. Hallmarks include:
Life expectancy here is shorter:
Factors that influence survival:
When decompensated cirrhosis advances toward end‐of‐life, the following signs often appear. Not everyone has all of them, but multiple warning signs together suggest urgency.
Facing end-stage cirrhosis is emotionally and physically challenging. Practical steps include:
If you or a loved one with stage 4 cirrhosis notice any of the following, seek medical attention immediately:
For non-urgent concerns, you might also try a free, online symptom check, using the doctor approved Ubie Symptom Checker. It can help you gauge which symptoms need prompt evaluation.
This is serious health information. Always speak to a doctor about any new or worsening symptoms, especially if life‐threatening. Early intervention can make a real difference in both comfort and survival.
(References)
* Moreau R, Jalan R, Gines P, Pavesi M, Angeli P, Cordoba J, Durand F, Gustot T, Saliba F, Domenicali M, Gerbes A, Wendon J, Alessandria C, Laleman W, Zeuzem S, Trebicka J, Bernardi M, Arroyo V, CANONIC Study Investigators of the EASL–CLIF Consortium. Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis. Gastroenterology. 2013 Jun;144(7):1426-37, 1437.e1-9. doi: 10.1053/j.gastro.2013.02.042. Epub 2013 Mar 6. PMID: 23474284.
* Lai JC, Covinsky KE, Dodge JL, Boscardin WJ, Segev DL, Roberts JP, Feng S. Development of a novel frailty index to predict mortality in patients with end-stage liver disease. Hepatology. 2017 Aug;66(2):564-574. doi: 10.1002/hep.29219. Epub 2017 Jun 28. PMID: 28422306; PMCID: PMC5519430.
* Mahmud N, Fricker Z, Hubbard RA, Ioannou GN, Lewis JD, Taddei TH, Rothstein KD, Serper M, Goldberg DS, Kaplan DE. Risk Prediction Models for Post-Operative Mortality in Patients With Cirrhosis. Hepatology. 2021 Jan;73(1):204-218. doi: 10.1002/hep.31558. Epub 2020 Dec 10. PMID: 32939786; PMCID: PMC7902392.
* Kim TH, Jung YK, Yim HJ, Baik JW, Yim SY, Lee YS, Seo YS, Kim JH, Yeon JE, Byun KS. Impacts of muscle mass dynamics on prognosis of outpatients with cirrhosis. Clin Mol Hepatol. 2022 Oct;28(4):876-889. doi: 10.3350/cmh.2022.0231. Epub 2022 Sep 19. PMID: 36117443; PMCID: PMC9597226.
* Kumar VV, Kothakota SR, Nair AK, Sasidharan M, Kareem H, Kanala J, Kumar CP. Impact of sarcopenia on post-liver transplant morbidity and mortality in cirrhotic patients. Indian J Gastroenterol. 2022 Oct;41(5):440-445. doi: 10.1007/s12664-022-01262-3. Epub 2022 Nov 7. PMID: 36342633.
* Trifan A, Minea H, Rotaru A, Stanciu C, Stafie R, Stratina E, Zenovia S, Nastasa R, Singeap AM, Girleanu I, Muzica C, Huiban L, Cuciureanu T, Chiriac S, Sfarti C, Cojocariu C. Predictive Factors for the Prognosis of Alcoholic Liver Cirrhosis. Medicina (Kaunas). 2022 Dec 16;58(12). doi: 10.3390/medicina58121859. Epub 2022 Dec 16. PMID: 36557061; PMCID: PMC9786187.
* Agarwal B, Cañizares RB, Saliba F, Ballester MP, Tomescu DR, Martin D, Stadlbauer V, Wright G, Sheikh M, Morgan C, Alzola C, Lavin P, Green D, Kumar R, Sacleux SC, Schilcher G, Koball S, Tudor A, Minten J, Domenech G, Aragones JJ, Oettl K, Paar M, Waterstradt K, Bode-Boger SM, Ibáñez-Samaniego L, Gander A, Ramos C, Chivu A, Stange J, Lamprecht G, Sanchez M, Mookerjee RP, Davenport A, Davies N, Pavesi M, Andreola F, Albillos A, Cordingley J, Schmidt H, Carbonell-Asins JA, Arroyo V, Fernandez J, Mitzner S, Jalan R. Randomized, controlled clinical trial of the DIALIVE liver dialysis device versus standard of care in patients with acute-on- chronic liver failure. J Hepatol. 2023 Jul;79(1):79-92. doi: 10.1016/j.jhep.2023.03.013. Epub 2023 May 31. PMID: 37268222.
* Mazumder NR, Fontana RJ. MELD 3.0 in Advanced Chronic Liver Disease. Annu Rev Med. 2024 Jan 29;75:233-245. doi: 10.1146/annurev-med-051322-122539. Epub 2023 Sep 26. PMID: 37751367.
* Cronst J, Prediger L, Pinto MA, Ferraz J, Mattos AZ, Alvares-DA-Silva MR, Kruel CRP, Chedid MF. PROGNOSTIC FACTORS OF LIVER TRANSPLANTATION FOR ACUTE-ON-CHRONIC LIVER FAILURE. Arq Bras Cir Dig. 2023;36:e1779. doi: 10.1590/0102-672020230061e1779. Epub 2023 Dec 8. PMID: 38088725; PMCID: PMC10712924.
* Tonon M, D'Ambrosio R, Calvino V, Tosetti G, Barone A, Incicco S, Gambino C, Gagliardi R, Borghi M, Zeni N, Piano S, Lampertico P, Angeli P. A new clinical and prognostic characterization of the patterns of decompensation of cirrhosis. J Hepatol. 2024 Apr;80(4):603-609. doi: 10.1016/j.jhep.2023.12.005. Epub 2023 Dec 17. PMID: 38110003.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.